NASDAQ / LIVE COMPANY INTELLIGENCE

TELA Bio, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTELA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TELA COVERAGE

What’s moving TELA Bio, Inc. now

Current reporting with the operating signal separated from the noise.

01
TELA Bio, Inc.: TELA Bio Reports First Quarter 2026 Financial Results

TELA Bio, Inc.: TELA Bio Reports First Quarter 2026 Financial Results

The story matters when it changes TELA Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q1 Loss, Beats Revenue Estimates

Investors are testing whether TELA Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

Investors are testing whether TELA Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
TELA Bio, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025

TELA Bio, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025

The story matters when it changes TELA Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript

TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript

Investors are testing whether TELA Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Strength Seen in TELA Bio, Inc. (TELA): Can Its 11.4% Jump Turn into More Strength?

Strength Seen in TELA Bio, Inc. (TELA): Can Its 11.4% Jump Turn into More Strength?

The story matters when it changes TELA Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TELA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-25 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-11 · Period 2026-06-09SEC ↗8-KMaterial company eventFiled 2026-05-12 · Period 2026-05-12SEC ↗8-KMaterial company eventFiled 2026-04-30 · Period 2026-04-29SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-06-09SEC ↗4Official SEC filingFiled 2026-07-17 · Period 2026-07-15SEC ↗
EARNINGS / QUARTERLY TRACKER

TELA Bio, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.